Roche has received EC approval for its humanised monoclonal antibody Gazyva, in combination with mycophenolate mofetil (MMF).

The Emirates Drug Establishment (EDE), in collaboration with the Drug Information Association (DIA), Middle East and Africa Office, organised the first Clinical Research Forum in the UAE at the ...

Inductive Bio has secured up to $21m in funding from ARPA-H to lead the development of AI drug-toxicity prediction models.

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

The U.K. company presented findings that its 360 e-Lung technology could potentially speed up the diagnosis of progressive pulmonary fibrosis by nearly two years in more than half of the patients ...

We came across a bullish thesis on BioMarin Pharmaceutical Inc. on Value investing subreddit by BearWithMeGM. In this article ...

Brown Advisory, an investment management company, released its “Brown Advisory Large-Cap Growth Strategy” third-quarter 2025 ...

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug ...

Published in the Journal of Pharmaceutical Analysis, the research explores how sweat could be used to follow changes in ...

The U.S. and UK have announced a pharmaceutical tariff and pricing deal in which the UK government agreed to increase investment in ...

Zhejiang Yangli Pharmaceutical Technology Co. Ltd. has synthesized thiazole-substituted pyrimidine amine compounds acting as CDK2/cyclin E1 inhibitors reported to be useful for the treatment of cancer ...

The U.K. has secured a 0 percent tariff rate for all U.K. medicines exported to the U.S. for at least three years, officials said Monday, in return for the U.K. spending more on new medicines.